← all drugs
Travoprost Ophthalmic Solution
being discontinued · Ophthalmology · Snapshot: 2026-10-09
- Manufacturers listed
- Mylan Pharmaceuticals Inc., a Viatris Company
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32) | Mylan Pharmaceuticals Inc., a Viatris Company | unknown | 07/07/2026 |
| Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50) | Mylan Pharmaceuticals Inc., a Viatris Company | unknown | 07/07/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.